Sonidegib: First Global Approval.

Sonidegib: First Global Approval.

Item
http://www.wikidata.org/entity/Q38577307
Hedgehog signaling: modulation of cancer properies and tumor mircroenvironmentPeroxisome proliferator activated receptors at the crossroad of obesity, diabetes, and pancreatic cancerAdjunct Strategies for Tuberculosis Vaccines: Modulating Key Immune Cell Regulatory Mechanisms to Potentiate VaccinationEstablishment of basal cell carcinoma animal model in Chinese tree shrew (Tupaia belangeri chinensis).Hedgehog signaling pathway affects the sensitivity of hepatoma cells to drug therapy through the ABCC1 transporter.The safety and efficacy of sonidegib for the treatment of locally advanced basal cell carcinoma.Mechanistic studies on intramolecular C-H trifluoromethoxylation of (hetero)arenes via OCF3-migration.Strategies to target the Hedgehog signaling pathway for cancer therapy.Pharmacological targeting of GLI1 inhibits proliferation, tumor emboli formation and in vivo tumor growth of inflammatory breast cancer cells.Synthesis and Investigation of S-Substituted 2-Mercaptobenzoimidazoles as Inhibitors of Hedgehog Signaling.Novel molecular insights and new therapeutic strategies in osteosarcoma
P2860

Sonidegib: First Global Approval.

Item
http://www.wikidata.org/entity/Q38577307
description
2015 nî lūn-bûn
@nan
2015年の論文
@ja
2015年論文
@yue
2015年論文
@zh-hant
2015年論文
@zh-hk
2015年論文
@zh-mo
2015年論文
@zh-tw
2015年论文
@wuu
2015年论文
@zh
2015年论文
@zh-cn
name
Sonidegib: First Global Approval.
@en
type
label
Sonidegib: First Global Approval.
@en
prefLabel
Sonidegib: First Global Approval.
@en
P1433
P1476
P2093
P2860
P2888
P304
P31
P356
P433
P478
P577
P6179
P698
P921
P356
P1433
P1476
Sonidegib: First Global Approval.
@en
P2093
P2860
P2888
P304
P31
P356
P433
P478
P577
P6179
P698
P921